Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Sanchez

Showing results (261-270 of 319) with videos related to

Pageof 32
Sort By:
Journal of Virology|January 31, 2023
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological DysfunctionClara Duran-Castells, Anuska Llano, Ai Kawana-Tachikawa, et al.
Eye (London, England)|September 21, 2024
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database studyMartín Puzo, Pilar Calvo-Perez, Francisco Bartol-Puyal, et al.
Ophthalmology. Retina|November 4, 2023
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular DegenerationJordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, et al.
Journal of Translational Medicine|December 14, 2011
Definition of the viral targets of protective HIV-1-specific T cell responsesBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
The Journal of Rheumatology|April 3, 2014
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohortMurray B Urowitz, Dafna D Gladman, Dominique Ibañez, et al.
Arthritis Care & Research|May 20, 2014
Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohortJosiane Bourré-Tessier, Murray B Urowitz, Ann E Clarke, et al.
The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.
Arthritis Care & Research|January 24, 2023
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate ModelingAnn E Clarke, John G Hanly, Murray B Urowitz, et al.
Annals of the Rheumatic Diseases|August 9, 2022
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohortManuel Francisco Ugarte-Gil, John Hanly, Murray Urowitz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception CohortJohn G Hanly, Caroline Gordon, Sang-Cheol Bae, et al.
Pageof 32

Showing results (261-270 of 319) with videos related to

Sort By:
Pageof 32
Journal of Virology|January 31, 2023
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological DysfunctionClara Duran-Castells, Anuska Llano, Ai Kawana-Tachikawa, et al.
Eye (London, England)|September 21, 2024
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database studyMartín Puzo, Pilar Calvo-Perez, Francisco Bartol-Puyal, et al.
Ophthalmology. Retina|November 4, 2023
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular DegenerationJordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, et al.
Journal of Translational Medicine|December 14, 2011
Definition of the viral targets of protective HIV-1-specific T cell responsesBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
The Journal of Rheumatology|April 3, 2014
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohortMurray B Urowitz, Dafna D Gladman, Dominique Ibañez, et al.
Arthritis Care & Research|May 20, 2014
Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohortJosiane Bourré-Tessier, Murray B Urowitz, Ann E Clarke, et al.
The Lancet. HIV|November 12, 2023
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trialRaphael J Landovitz, Brett S Hanscom, Meredith E Clement, et al.
Arthritis Care & Research|January 24, 2023
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate ModelingAnn E Clarke, John G Hanly, Murray B Urowitz, et al.
Annals of the Rheumatic Diseases|August 9, 2022
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohortManuel Francisco Ugarte-Gil, John Hanly, Murray Urowitz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception CohortJohn G Hanly, Caroline Gordon, Sang-Cheol Bae, et al.
Pageof 32